Publication | Closed Access

Effect of reboxetine, a new antidepressant drug, on the central noradrenergic system: Behavioural and biochemical studies

Psychotropic MedicationPsychopharmacologyCentral Noradrenergic SystemPharmacotherapyExperimental PharmacologySocial SciencesBiochemical StudiesPsychoactive DrugPsychiatryBehavioral NeuroscienceBehavioural PharmacologyBehavioral PharmacologyDepressionNeuropharmacologyNervous SystemPharmacologyNew Antidepressant DrugNeuroscienceBiological PsychiatryMedicinePsychopathology